North Growth Management’s Gilead Sciences GILD Stock Holding History

North Growth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-142,000	Closed	-$9.93M	–	52
2021 Q3	$9.93M	Hold	142,000	–	–	1.75%	28
2021 Q2	$9.76M	Buy	142,000 +1,000	+0.7%	+$66.8K	1.59%	33
2021 Q1	$9.13M	Hold	141,000	–	–	1.62%	30
2020 Q4	$8.22M	Sell	141,000 -11,000	-7%	-$664K	1.68%	33
2020 Q3	$9.59M	Buy	152,000 +15,000	+11%	+$1.04M	2.11%	23
2020 Q2	$10.6M	Sell	137,000 -5,000	-4%	-$383K	2.53%	16
2020 Q1	$10.6M	Sell	142,000 -33,000	-19%	-$2.28M	2.97%	8
2019 Q4	$11.4M	Hold	175,000	–	–	2.55%	14
2019 Q3	$11.1M	Buy	175,000 +15,000	+9%	+$981K	2.68%	15
2019 Q2	$10.8M	Hold	160,000	–	–	2.67%	11
2019 Q1	$10.4M	Hold	160,000	–	–	2.78%	12
2018 Q4	$9.99M	Hold	160,000	–	–	2.8%	13
2018 Q3	$12.3M	Hold	160,000	–	–	3.12%	8
2018 Q2	$11.3M	Buy	160,000 +18,000	+13%	+$1.27M	2.85%	9
2018 Q1	$10.7M	Hold	142,000	–	–	2.76%	9
2017 Q4	$10.2M	Buy	+142,000	New	+$10.8M	2.67%	16

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

North Growth Management's GILD Position: Q4 2021 in Review

North Growth Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 142,000 shares — an estimated $9.93M sold.

North Growth Management first reported a position in GILD in Q4 2017 and held it in 16 quarters. The position peaked at $12.3M in Q3 2018. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

North Growth Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
North Growth Management sold 142,000 Gilead Sciences shares in Q4 2021, an estimated $9.93M.
North Growth Management first reported a position in Gilead Sciences in Q4 2017 and held it in 16 quarters.
North Growth Management's Gilead Sciences position peaked at $12.3M in Q3 2018.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on North Growth Management's 13F filing for Q4 2021, filed 7 Feb 2022.